Latest Insider Transactions at 89bio, Inc. (ETNB)
This section provides a real-time view of insider transactions for 89bio, Inc. (ETNB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of 89bio, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of 89bio, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 16
2020
|
Quoc Le Nguyen |
BUY
Exercise of conversion of derivative security
|
Direct |
4,548
+50.0%
|
$13,644
$3.11 P/Share
|
|
Nov 16
2020
|
Gregory Grunberg Director |
BUY
Other acquisition or disposition
|
Direct |
850
+50.0%
|
-
|
|
Nov 16
2020
|
Gregory Grunberg Director |
SELL
Other acquisition or disposition
|
Indirect |
850,000
-32.68%
|
-
|
|
Nov 16
2020
|
Longitude Capital Partners Iii, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
5,944
+50.0%
|
-
|
|
Nov 16
2020
|
Longitude Capital Partners Iii, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
850,000
-32.68%
|
-
|
|
Sep 21
2020
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
275,000
-6.87%
|
$7,700,000
$28.0 P/Share
|
|
Sep 17
2020
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
1,300,000
+21.54%
|
$36,400,000
$28.0 P/Share
|
|
Jul 08
2020
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
275,000
+7.41%
|
$7,425,000
$27.5 P/Share
|
|
Nov 13
2019
|
Ra Capital Management, L.P. |
BUY
Conversion of derivative security
|
Indirect |
1,661,214
+34.45%
|
-
|
|
Nov 13
2019
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,555,716
+38.96%
|
-
|
|
Nov 11
2019
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
1,500,000
+50.0%
|
$24,000,000
$16.0 P/Share
|
|
Nov 11
2019
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
837,500
+36.63%
|
$13,400,000
$16.0 P/Share
|